Marksans Pharma zooms on getting USFDA’s approval for Cetirizine Hydrochloride Tablets
Marksans Pharma is currently trading at Rs. 63.95, up by 2.30 points or 3.73% from its previous closing of Rs. 61.65 on the BSE. The scrip opened at Rs. 61.50 and has touched a high and low of Rs. 64.50 and Rs. 61.45 respectively. So far 438713 shares were traded on the counter. The BSE … Read more
